/stocks — the workspaceLOADING
All BAX SEC filings, by type → · Earnings date & implied move · Search inside filings
BAXTER INTERNATIONAL INC (BAX) is a surgical & medical instruments & apparatus company. Piotroski F-Score 5/8. 3 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-10-29 from BAX's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind BAX’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
eight-variable model; a screen for earnings-quality review, not an accusation
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from BAX’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on BAX plus an auto-SWOT — built from BAX's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate BAX using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has BAX been issuing shares? Offering history →
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
No lawmaker has disclosed a trade in BAX under the STOCK Act.
Projected from BAX's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentBAX files or announces.
BAX has sold off after 5 of its last 8 earnings reports.
Each figure is one earnings reaction — how much BAX moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Large earnings reactions have been common.
BAX has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+9.7% and -21.7%).
A more typical earnings reaction has been approximately ±7.7%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-07-30 | +5.6% |
| 2026-04-30 | +1.8% |
| 2026-02-12 | -11.1% |
| 2025-10-30 | -17.6% |
| 2025-07-31 | -21.7% |
| 2025-05-01 | -1.5% |
| 2025-02-20 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +9.7% |
| 2024-11-08 | -5.0% |
No tracked institution reported a position in BAX in the latest 13F round.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30 to 2026-07-31, not today.
| Fund | Weight | As of |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.25% | 2026-07-31 |
| XLV Health Care Select Sector SPDR | 0.19% | 2026-06-30 |
| VYM Vanguard High Dividend Yield ETF | 0.05% | 2026-07-31 |
| IWD iShares Russell 1000 Value ETF | 0.03% | 2026-06-30 |
| SPY SPDR S&P 500 ETF Trust | 0.02% | 2026-06-30 |
| VOO Vanguard S&P 500 ETF | 0.02% | 2026-06-30 |
| IVV iShares Core S&P 500 ETF | 0.02% | 2026-06-30 |
| IWB iShares Russell 1000 ETF | 0.02% | 2026-06-30 |
| ITOT iShares Core S&P Total US Stock Market ETF | 0.02% | 2026-06-30 |
| VTI Vanguard Total Stock Market ETF | 0.02% | 2026-06-30 |
Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
Free cash flow does not currently cover the dividend. That is the single most important test here, and it failing outweighs the tests that passed.
The score is passed over computable, not passed out of five. If only three tests could be run on BAX’s filings, the score is out of three and the other two are listed with the reason they were skipped. Scoring a skipped test as a failure would punish a company for how its industry reports, and scoring it as a pass would flatter one.
Labels come from that ratio:
Below three computable tests we publish no label at all and show the individual results instead. A summary drawn from one or two tests is not a summary.
Free cash flow coverage carries the most weight in practice, because dividends are paid in cash and free cash flow is the cash actually available to pay them. The earnings payout ratio is the better-known test but the weaker one — earnings are an accounting figure, dividends are not. Where the two disagree, believe the cash.
Why tests get skipped. A REIT gets no earnings payout ratio: GAAP depreciation on appreciating property understates a REIT’s distributable earnings, which is exactly why the industry reports FFO and why REITs are required to distribute most of their taxable income. Banks and insurers get no leverage test, because deposits are debt and structurally high leverage is what a balance-sheet business is, not a warning sign.
The biggest limitation, stated plainly. The coverage tests read a single fiscal year, and one year of cash flow is far more volatile than a dividend record. A legal settlement, a tax payment or an acquisition can sink coverage in a year that says nothing about the dividend. Where a weak year contradicts a long unbroken record, we say so above rather than letting the harsher number stand alone — but you should still check what happened in that specific year.
The streak is the weakest test here, and it is deliberately listed last. Every dividend that was ever cut had an unbroken streak right up until the year it was cut. A freeze does not break the run — a company that holds its dividend flat through a bad year has not cut it — so raises are counted separately, and a long flat run cannot pass itself off as dividend growth.
Every figure above is from BAX’s own SEC filings and the arithmetic is stated on this page. This describes what the filings show about the dividend’s coverage — it is not a prediction that the dividend will or will not be cut, not a recommendation, and not investment advice. A covered dividend can still be cut, and a strained one can still be maintained for years. Educational information only.
Shareholder returns exceeded free cash flow this period — the difference was funded from cash on hand, debt, or asset sales rather than the business itself. Common and sustainable for a period; worth watching if it persists.
Every figure is from BAX’s SEC cash-flow statement. This describes how management deployed cash last period — it is not a grade of that deployment, not a forecast, and not investment advice. Whether reinvesting, paying down debt, or returning cash was the right call depends on the return each earns, which the filings do not settle. Educational information only.
Head office: Deerfield, Illinois, United States · the company’s charter and its head office are in different states.
Source: the cover page of BAXTER INTERNATIONAL INC’s 10-Q filed 2026-07-30, on EDGAR. Filings checked 2026-10-14. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
No open-market Form 4 buys or sells reported for BAX in the last ~6 months.